AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 DEC 10 - (NewsRx.com & NewsRx.net) -- A new MAGE-4 antigenic peptide is recognized by cytolytic T lymphocytes on HLA-A1 tumor cells.
"'Cancer-germline' genes such as those of the MAGE family are expressed in many tumors and in male germline cells, but are silent in other normal tissues. They encode shared tumor-specific antigens, which have been used in small therapeutic vaccination trials of cancer patients. Gene MAGE-4, which is expressed in more than 50% of carcinomas of esophagus, head and neck, lung, and bladder, has two known alleles," scientists in Belgium report.
"Using PCR amplifications and digestions of the amplified product, we found that one third of the MAGE-4-positive samples expressed MAGE-4a," said T. Kobayashi and colleagues at the University of Louvain. "We folded HLA-A1 tetramers with peptide MAGE-4a[subscript]169-177 EVDPASNTY, which is homologous to MAGE-1- and MAGE-3-encoded peptides recognized on HLA-A1 by cytolytic T lymphocytes. Blood lymphocytes from an individual without cancer were directly labeled with these A1/MAGE-4 tetramers. The very rare cells that were stained were sorted by flow cytometry and ...